Filing metadata

Accession number
0000905148-25-001257
Form type
Form 4
Filer
Acrivon Therapeutics, Inc.
CIK
CIK 1781174
Filed
Apr 18, 2025
Reporting period
Apr 17, 2025
Description
Insider transaction

Explore SEC Filings Hub